Billur Dowse is a Board Director at HCMA and an active volunteer. Billur was the Acting Chairperson for the Elizabeth T. McNamee Legislative Advocacy Committee from October 2019 through June 2023. Billur joined HCMA in 2018 as a member and a volunteer.

After her diagnosis with HOCM in 2017, Billur had to retire early after spending a total of 25 years in the healthcare industry. In December 2017, Billur retired from Merck after serving for 15.5 years as the Director of Global Market Access and Pricing. At Merck, Billur held many different levels of responsibilities within access, pricing, and launching of new products globally. Billur was responsible for US and ex-US markets mainly dealing with payers, which included governments, agencies, and insurance companies as well as the development of Patient Assistance Programs for infectious disease products and vaccines. Prior to Merck, Billur was with IMS Health, now IQVIA, and prior to IMS, she was with the University of Pennsylvania Health System for five years working on patient care issues, development of treatment algorithms, and measuring outcomes all based on real-world evidence, as well as obtaining the patient voice through surveys related to their care.